Orchard Therapeutics plc
ORTXDelisted Jan 24, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001748907
Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Orchard Therapeutics plc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 72 | 1 | 61 | −10 |
| Shares | 64.1M | 10.0K | 54.6M | −9.46M (−14.8%) |
| Value | $84.6M | $13.2K | $38.9M | −$45.7M (−54.0%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Orchard Therapeutics plc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 26,079 | $18.0K | 0.00% |
| HRT Financial LP | 25,989 | $18.0K | 0.00% |
| JustInvest LLC | 16,259 | $12.0K | 0.00% |
| Oppenheimer & Co Inc | 11,600 | $8.00K | 0.00% |
| Running Point Capital Advisors, LLC | 10,703 | $8.00K | 0.00% |
| Connecticut Wealth Management, LLC | 10,000 | $7.00K | 0.00% |
| Captrust Financial Advisors | 750 | $1.00K | 0.00% |
| Dixon Hughes Goodman Wealth Advisors LLC | 125 | $0 | 0.00% |
Sold out (18)
Institutions that held Orchard Therapeutics plc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Platinum Investment Management Ltd | 1,335,174 | $1.76M |
| Two Sigma Investments, LP | 542,212 | $716.0K |
| Woodline Partners LP | 361,736 | $477.0K |
| Anson Funds Management LP | 348,266 | $460.0K |
| Millennium Management LLC | 142,992 | $189.0K |
| Acadian Asset Management LLC | 108,165 | $141.0K |
| Jane Street Group, LLC | 80,648 | $106.0K |
| Susquehanna International Group, LLP | 67,465 | $89.0K |
| Group One Trading, L.P. | 52,261 | $69.0K |
| Two Sigma Securities, LLC | 46,311 | $61.0K |
| Engineers Gate Manager LP | 30,326 | $40.0K |
| Marshall Wace, LLP | 23,547 | $31.0K |
| Ergoteles LLC | 23,172 | $31.0K |
| Simplex Trading, LLC | 17,773 | $23.0K |
| Squarepoint Ops LLC | 14,740 | $19.0K |
| Kestra Private Wealth Services, LLC | 10,033 | $13.0K |
| Matisse Capital | 10,000 | $13.0K |
| Edge Wealth Management LLC | 220 | – |
Not filed for Q1 2022 yet (1)
Institutions that held Orchard Therapeutics plc at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| PVG Asset Management Corp | 10,000 | $13.2K |